Ville Sallinen, Arto Kokkola, Pauli Puolakkainen
JAMA Surg . 2024 Oct 1;159(10):1147-1148. doi: 10.1001/jamasurg.2024.2486.
The treatment sequence in resectable pancreatic cancer remains a debate as randomized studies have not been able to show superiority of neoadjuvant therapy over up-front surgery.